Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-449
Closed -$205K 315
2023
Q4
$205K Sell
449
-144
-24% -$71K 0.01% 269
2023
Q3
$288K Sell
593
-72
-11% -$33.8K 0.02% 199
2023
Q2
$304K Buy
665
+33
+5% +$16.6K 0.02% 231
2023
Q1
$307K Buy
+632
New +$312K 0.02% 210

Other funds holding HUM

Trilogy Capital's HUM Position: Q1 2024 in Review

Trilogy Capital sold out of Humana (HUM) in Q1 2024, closing a stake of 449 shares — an estimated $205K sold.

Trilogy Capital first reported a position in HUM in Q1 2023 and held it in 4 quarters. The position peaked at $307K in Q1 2023. 1,029 funds tracked by Wall St. Rank hold HUM as of Q1 2024.

  • Trilogy Capital reported no remaining Humana position as of Q1 2024 after selling out during the quarter.
  • Trilogy Capital sold 449 Humana shares in Q1 2024, an estimated $205K.
  • Trilogy Capital first reported a position in Humana in Q1 2023 and held it in 4 quarters.
  • Trilogy Capital's Humana position peaked at $307K in Q1 2023.
  • 1,029 funds tracked by Wall St. Rank held Humana as of Q1 2024.

Based on Trilogy Capital's 13F filing for Q1 2024, filed 17 Apr 2024.